BOOK
European Union As A Global Health Actor, The
Emmerling Thea | Kickbusch Ilona | Told Michaela
(2016)
Additional Information
Book Details
Abstract
This book provides a systematic collection of EU actors, EU policy and EU actions in global health. It answers key questions on governance of the EU and its policy processes. The book starts with an introduction to the EU as a global actor and continues to outline the historical development and the Treaty basis for health, including the Maastricht and Lisbon Treaties. It also discusses the Commission's global health communication and the subsequent Council Conclusions on global health. Both documents define EU values in global health and identify the future priorities for global health action in the EU. Four of the five priorities are then described from the perspective of a different country experience. The book also considers the opportunities for research and provides an overview of the political, legal and financial instruments available to the EU. It also explores the global health architecture and processes within which the EU is acting, namely at the WHO, in the different multilateral organizations, and in global public health international treaties and regulations. Finally, the book addresses the importance of policy coherence at a national level and provides critical viewpoint on the EU as a global health actor.The book will assist practitioners working in policy making and international negotiations affecting health, as well as students and researchers, to create a better understanding of the European Union, its role in global health, and the uniqueness and specificity of the EU as a global health actor. It provides an overview of how the EU can act in global health and outlines the intersections of health and other sectors, as well as the instruments available to the EU to act effectively at a global level. The collection of contributions in this form and from this health policy perspective are not yet found elsewhere on the market.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Contents | v | ||
List of Contributors | vii | ||
Chapter 1 The EU as a Global Actor | 1 | ||
Introduction | 1 | ||
Foreign Policy with the EU’s Actor Characteristics | 2 | ||
The EU’s International Policies | 6 | ||
The EU in International Diplomacy: Bilateral and Multilateral Relations | 9 | ||
Bilateral Relations | 10 | ||
Multilateral Relations | 14 | ||
Conclusions and Broader Perspectives | 16 | ||
References | 18 | ||
Chapter 2 The Development of EU Health Policy: Treaty Basis, Health Acquis and History | 21 | ||
The Treaty Basis\r | 21 | ||
The Health-related Acquis Communautaire\r | 32 | ||
The Public Health Programs | 73 | ||
Institutional Developments | 76 | ||
Commission | 76 | ||
European Agencies | 77 | ||
European Parliament | 78 | ||
Council | 79 | ||
Relations with Stakeholders | 79 | ||
External Action and International Cooperation in Health | 81 | ||
Outlook | 87 | ||
References | 88 | ||
Chapter 3 Why and How Did the EU Set a Policy in Global Health? | 93 | ||
The Context | 93 | ||
The Process | 97 | ||
The Commission Communication | 98 | ||
The Council Conclusions | 102 | ||
Conclusion | 103 | ||
Chapter 4 Trade and Health: A Healthy Relationship? The Place of Trade Policy in the EU’s Global Health Agenda | 105 | ||
The Place of Trade Policy in the EU Global Health Strategy | 107 | ||
Access to Medicines and Intellectual Property Rights | 109 | ||
The Political Trade Policy Context for the EU Global Health Strategy | 112 | ||
The EU’s Trade Policy Response to Improve Access to Medicines | 115 | ||
EU Policy in Respect of Patent-Related TRIPS Flexibilities | 115 | ||
Bilateral Trade Negotiations | 119 | ||
Tiered Pricing | 122 | ||
Conclusion | 123 | ||
References | 124 | ||
General References | 128 | ||
Chapter 5 EU Global Health Priorities: Migration and Mobility | 129 | ||
Introduction | 129 | ||
The EU’s Role in Global Health: Migrants’ Health | 131 | ||
EU Regulatory Framework, Strategies, and Action on Migrants’ Health | 133 | ||
The EU’s Role in Global Health: Migration of Human Resources for Health | 137 | ||
Mobility of Human Resources for Health Within the EU — Issues, Strategies and Policy Responses | 138 | ||
Mobility of Human Resources for Health to and from the EU — Issues and Policy Responses | 140 | ||
Progress Toward Better Management of Health Worker Mobility: Country Examples from the EU/EEA | 143 | ||
Conclusion | 144 | ||
References | 145 | ||
Chapter 6 EU Global Health Priorities: Climate Change | 149 | ||
Introduction | 149 | ||
Climate Change as a Threat to Global Health | 150 | ||
The EU at UNFCCC Climate Change Negotiations: Legal Basis | 151 | ||
Global Health at UNFCCC COP Negotiations | 153 | ||
The EU’s Role at the COP16 Negotiations | 153 | ||
The EU’s Role at the COP17 Negotiations | 157 | ||
The EU’s Role at Rio+20 | 159 | ||
Conclusion and Outlook | 159 | ||
References | 160 | ||
Chapter 7 Research, Development and Innovation for Global Health | 167 | ||
Introduction: Scope of the Field | 168 | ||
Global Health | 168 | ||
Research, Development and Innovation (RDI) | 169 | ||
Elements of the EU’s Role in RDI for Global Health | 170 | ||
Policy Goals | 171 | ||
EU Engagement in Global Health R&D Policies and Partnership Initiatives | 172 | ||
UN debates and initiatives | 172 | ||
Globally coordinated action on health R&D | 176 | ||
EU Funding for Global Health R&D | 179 | ||
Framework programs for research and technological development (FPs) | 179 | ||
EU research framework programme 7 | 180 | ||
Support for R&D relevant to health in LMICs | 183 | ||
Horizon 2020 (FP8) and Europe 2020 | 188 | ||
RDI for global health in EU development policy | 189 | ||
Ethics, Regulatory and Legal Roles and RDI for Global Health | 190 | ||
Clinical trials | 190 | ||
Registration of drugs predominantly for use in LMICs | 192 | ||
Key Challenges for Current European and Global R&D Policy | 193 | ||
Content/Issue Challenges | 194 | ||
Balancing the need for economic growth with equity concerns | 194 | ||
Capacity building in LMICs; promoting health equity and sustainable development | 194 | ||
Innovation policy and global public goods | 195 | ||
Governance Challenges | 195 | ||
Meeting the challenge of the multisectoral and multidisciplinary nature of global health | 195 | ||
Stakeholder participation, transparency and accountability | 196 | ||
New ethical challenges and gain-of-function research | 196 | ||
Political/Implementation Challenges | 197 | ||
Conclusion | 197 | ||
References | 198 | ||
Chapter 8 Humanitarian Aid, the Global Health Communication and the Council Conclusions on the EU Role in Global Health | 215 | ||
Humanitarian Aid in the Global Health Communication and the Council Conclusions | 216 | ||
The GHC and CC Elements related to Humanitarian Aid | 219 | ||
Outlook: What is Ahead of Us? | 221 | ||
References | 222 | ||
Chapter 9 The Consideration of Health in EU Financial Programmes | 225 | ||
The EU Budget and Financial Perspectives | 226 | ||
Specific Health Programme and Mainstreaming of Health Activities | 228 | ||
Mainstreaming Health — Financial Instruments for Internal Policies | 231 | ||
Mainstreaming Health — Financial Instruments for External Policies | 234 | ||
How Much Money for Health in the EU Budgets for 2014–2020? | 244 | ||
Conclusion | 249 | ||
Chapter 10 Law and the EU Role in Global Health Strategies: The Case of the FCTC | 251 | ||
The FCTC | 251 | ||
The EU and the FCTC | 252 | ||
The Dynamics of the Decision-Making Processes to Define the EU Negotiation Positions | 255 | ||
Approval or Ratification and FCTC Implementation in the EU | 258 | ||
The FCTC Protocol on Illicit Trade in Tobacco Products | 261 | ||
The FCTC as a Success Story | 263 | ||
Conclusion | 264 | ||
References | 265 | ||
Chapter 11 The EU’s Role in the International Health Regulations and the Pandemic Influenza Preparedness Framework Agreement | 269 | ||
Introduction | 269 | ||
Background and Brief Description of the Two Global Health Security Instruments | 270 | ||
The International Health Regulations | 270 | ||
The Pandemic Influenza Preparedness Framework Agreement | 272 | ||
The EU Role in the Two Global Health Security Agreements | 274 | ||
The EU Role in the International Health Regulations | 275 | ||
The EU Role in the Pandemic Influenza Preparedness Framework Agreement | 277 | ||
Conclusion | 278 | ||
Acknowledgment | 279 | ||
References | 279 | ||
Chapter 12 The EU Voice in the UN System Related to Health and Other Health Actors | 281 | ||
The European Union’s Mandate in Global Health | 281 | ||
World Health Organization | 284 | ||
Cooperation between the European Commission and the WHO | 284 | ||
The EU’s Participation in the WHO | 287 | ||
EU representation at the WHO | 291 | ||
Joint United Nations Programme on HIV/AIDS | 293 | ||
Global Fund to Fight AIDS, Tuberculosis and Malaria | 294 | ||
Conclusions | 296 | ||
References | 298 | ||
Chapter 13 Germany’s Role in Promoting Systems of Solidarity in Healthcare | 301 | ||
Why is Social Health Protectionb an Issue in Global Health? | 301 | ||
I Did it My Way: Germany’s Path Toward Social Health Protection for All | 303 | ||
Together We Stand Strong: Principles Underlying SHP in the German Context | 306 | ||
With a Little Help from My Friends: Instruments to Promote SHP Globally | 307 | ||
Imagine All the People …: The Shaping of Discourse and the Promotion of Norms Internationally | 309 | ||
Acknowledgments | 311 | ||
References | 311 | ||
Chapter 14 The Civil Society Perspective on the EU’s Role in Global Health | 313 | ||
Background: Multiple Actor Governance in Global Health | 313 | ||
The Malaise of Corporate Capture | 315 | ||
The Involvement of Public Interest Civil Society in EU Public Health Policies | 316 | ||
NGOs and Global Health | 317 | ||
The EU Role in Global Health and the Global Health Policy Platform | 319 | ||
CSOs’ Interaction with the European Parliament in Global Health | 321 | ||
Prospects of the EU Role in Global Health and the Role of Civil Society | 325 | ||
Acknowledgments | 326 | ||
References | 327 | ||
Chapter 15 The European Union as a Global Health Actor: A Critical View | 329 | ||
Introduction | 329 | ||
EU Coherence on Global Health Questions | 332 | ||
Policy Determinacy: EU Competence and Positions on Health and Global Health | 333 | ||
Political Cohesion between EU Actors and EU Member States: The Single Voice Challenge | 337 | ||
Effectiveness of the EU in Debates on Gobal Health | 341 | ||
The EU’s Effectiveness in the Debate on WHO Reform | 342 | ||
UN Debate on NCDs and SDOH | 344 | ||
Relating Coherence and Effectiveness | 346 | ||
Conclusion | 349 | ||
References | 350 | ||
Index | 355 |